NCT01983527

Brief Summary

Arthrographic distention of the shoulder joint is an increasingly popular treatment option in the management of patients with frozen shoulder. Most have included the intra-articular injection of a corticosteroid as part of the procedure, but it is not known if this is necessary. It is also not known whether arthrographic distention using steroid and saline is better than intra-articular steroid injection alone. The purpose of this study is to determine whether there is an additional benefit in the combination of arthrographic distention plus intra-articular corticosteroid injection compared to arthrographic distention or intra-articular corticosteroid injection alone.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
132

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2013

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 7, 2013

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 14, 2013

Completed
17 days until next milestone

Study Start

First participant enrolled

December 1, 2013

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2014

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2015

Completed
Last Updated

November 14, 2013

Status Verified

November 1, 2013

Enrollment Period

1 year

First QC Date

November 7, 2013

Last Update Submit

November 13, 2013

Conditions

Keywords

Arthrographic distentionHydrodilatationIntra-articular corticosteroid injection

Outcome Measures

Primary Outcomes (1)

  • Shoulder pain and disability index(SPADI)

    4 weeks

Secondary Outcomes (3)

  • Shoulder pain and disability index (SPADI)

    weekly for a period of 3 months plus at follow-up (4 months and 12 months)

  • Overall pain score

    weekly for a period of 3 months, plus at follow-up (4 months and 12 months)

  • Range of motion

    4 weeks, 4 months and 12 months

Study Arms (3)

Arthrographic distention + intra-articular corticosteroid

EXPERIMENTAL

Arthrographic distention of the glenohumeral joint with injection of 5 ml contrast, 1 ml (40 mg) Depo Medrol(Methylprednisolone Acetate Injectable Suspension), 15 ml local anaesthetic (Prilocaine) and up to 15 ml saline.

Procedure: Arthrographic distentionDrug: Intra-articular corticosteroid Depo Medrol

Arthrographic distention

ACTIVE COMPARATOR

Arthrographic distention of the glenohumeral joint with injection of 5 ml contrast, 15 ml local anaesthetic (Prilocaine) and up to 15 ml saline.

Procedure: Arthrographic distention

Intra-articular corticosteroid

ACTIVE COMPARATOR

Arthrographic pseudodistention of the glenohumeral joint with injection of 5 ml contrast and 1 ml (40 mg) Depo Medrol(Methylprednisolone Acetate Injectable Suspension).

Drug: Intra-articular corticosteroid Depo Medrol

Interventions

Arthrographic distention of the glenohumeral joint with injection of 5 ml contrast, 15 ml local anaesthetic (Prilocaine) and up to 15 ml saline.

Also known as: Hydrodilatation
Arthrographic distentionArthrographic distention + intra-articular corticosteroid

Intra-articular injection of 1 ml (40 mg) Depo Medrol(Methylprednisolone Acetate Injectable Suspension)

Arthrographic distention + intra-articular corticosteroidIntra-articular corticosteroid

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Pain and stiffness in predominantly 1 shoulder for 4 weeks or longer
  • Restriction of passive motion of greater than 30° in 2 or more planes of movement (measured to onset of pain with goniometer)

You may not qualify if:

  • Previous arthrographic distention and/or corticosteroid injection
  • Systemic inflammatory joint disease
  • Radiological evidence of osteoarthritis of the shoulder or fracture
  • Signs of a complete rotator cuff tear
  • Contraindications to arthrogram and/or distention
  • Lack of written informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Imelda Hospital

Bonheiden, Antwerpen, 2820, Belgium

Location

Related Publications (5)

  • Jacobs LG, Barton MA, Wallace WA, Ferrousis J, Dunn NA, Bossingham DH. Intra-articular distension and steroids in the management of capsulitis of the shoulder. BMJ. 1991 Jun 22;302(6791):1498-501. doi: 10.1136/bmj.302.6791.1498.

    PMID: 1855018BACKGROUND
  • Corbeil V, Dussault RG, Leduc BE, Fleury J. [Adhesive capsulitis of the shoulder: a comparative study of arthrography with intra-articular corticotherapy and with or without capsular distension]. Can Assoc Radiol J. 1992 Apr;43(2):127-30. French.

    PMID: 1562888BACKGROUND
  • Gam AN, Schydlowsky P, Rossel I, Remvig L, Jensen EM. Treatment of "frozen shoulder" with distension and glucorticoid compared with glucorticoid alone. A randomised controlled trial. Scand J Rheumatol. 1998;27(6):425-30. doi: 10.1080/030097498442244.

    PMID: 9855212BACKGROUND
  • Buchbinder R, Green S, Forbes A, Hall S, Lawler G. Arthrographic joint distension with saline and steroid improves function and reduces pain in patients with painful stiff shoulder: results of a randomised, double blind, placebo controlled trial. Ann Rheum Dis. 2004 Mar;63(3):302-9. doi: 10.1136/ard.2002.004655.

    PMID: 14962967BACKGROUND
  • Khan AA, Mowla A, Shakoor MA, Rahman MR. Arthrographic distension of the shoulder joint in the management of frozen shoulder. Mymensingh Med J. 2005 Jan;14(1):67-70.

    PMID: 15695959BACKGROUND

MeSH Terms

Conditions

Bursitis

Condition Hierarchy (Ancestors)

Joint DiseasesMusculoskeletal Diseases

Study Officials

  • Rolf Symons, MD

    Imeldaziekenhuis

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Symons Rolf, MD

Study Record Dates

First Submitted

November 7, 2013

First Posted

November 14, 2013

Study Start

December 1, 2013

Primary Completion

December 1, 2014

Study Completion

November 1, 2015

Last Updated

November 14, 2013

Record last verified: 2013-11

Locations